Skip to main content

      The Company

      We bring innovation to Greece with high quality pharmaceutical products

      UNI-PHARMA belongs to the Tsetis Group of Pharmaceutical Companies and has been operating for more than half a century of life.

      UNI-PHARMA today is a large and dynamic pharmaceutical industry that researches, develops, produces and distributes pharmaceutical products, food supplements and medical devices of innovative technology for drug delivery of the highest quality, effectiveness and safety.

      It holds the first place in sales (units) among the purely Greek companies of the Greek pharmaceutical market and does not stop. It continues to grow its portfolio and the markets where it operates daily. UNI-PHARMA’ s main objective is to achieve its introduction into new markets by producing innovative products and to ensure long-term growth exclusively by its own funds.

      At UNI-PHARMA, every move is aimed…

      …to be the first choice of doctors and pharmacists with innovative and value-added products.

      …to enter the homes of thousands of families on a daily basis and contribute to their health and quality of life.

      …to stand by its employees with pride and humaneness.

      …to boost its (work)force with young capable scientists by giving them opportunities to come forth in their country.

      …to contribute to the economic development of Greece through transparent management, consistency and discipline in laws and rules.

      …to open up to new markets that meet the conditions for accepting the range of UNI-PHARMA products.

      …to remain as one of the most successful examples of the business history of this country.

      Our vision

      UNI-PHARMA has a vision: to serve health with passion, creativity and ethics, being the leader in an ever-changing pharmaceutical market and by providing quality, innovative, safe and effective products to everyone.

      Our vision is to improve people’s lives

      That is why the company is a dynamic investor in modern production units and advanced technologies, in proactive people with high qualifications and ethics, in organizational systems that guarantee responsibility and participation, in partners and academic institutions, always with consistency and dedication to the values that distinguish its team.

      Because, for UNI-PHARMA, human life is the absolute priority.

      Kleon Tsetis Foundation

      Learn more about NPO Foundation

      Our values

      Each activity is based on the corporate values of UNI-PHARMA. They are the ones that keep the vision of UNI-PHARMA alive, both on an organizational and personal level.

      Our values are our guiding compass

      All activities are based on its corporate values. They are the ones that help keep the vision of UNI-PHARMA alive, both on an organizational and personal level.

      The initials of the corporate values create the word “TELEIA” (means ‘perfect’ in Greek), so that every member of the team can always remember them. That is the reason they remain unchanged over time, constituting the foundation of the company’s success.

      T for Teamwork

      Everyone always works together as a team to achieve more in a collaborative and supportive work environment.

      E for Ethos – Ethics

      Everyone's priority is to secure high ethical standards. That is why every activity is guided by the rules of transparency, ethics, and meritocracy, at all levels.

      L for Learning

      Every day is an opportunity for everyone to learn more and evolve by embracing the challenges of the times, thus investing in human resources.

      E for Excellence

      Excellence is a key pursuit, both at individual and corporate level, and a standing out point for UNI-PHARMA. The company moves forward energetically, encouraging its people to nurture high standards.

      I for Innovation

      UNI-PHARMA creates innovative products that meet modern needs. It invests in modern technologies and research, aiming to make innovative, signature products.

      A for Accountability

      Always with responsibility, the company considers the social dimension of each action and protects the environment, best responding to the challenges of our times for sustainable development.

      Our history

      Since 1964, UNI-PHARMA has been creating value in the pharmaceutical industry. And it has a worth hearing story. Discover the most important milestones in its course.

      A history of innovation in the search for medicines
      1964
      2025

      1964

      The dynamic start of UNI-PHARMA

      UNI-PHARMA begins its journey shortly after the mid-20th century.
      It was founded in 1964 by the pioneering pharmacist and researcher Kleon Tsetis. His vision was to strengthen the presence of Greek companies in the pharmaceutical industry through the development, production, and distribution of innovative medicines. From its very first year, UNI-PHARMA stood out as it became the first company worldwide to introduce phenobarbital as an oral solution, LUMIDROPS®, as well as a combination of phenobarbital and homatropine, NOVALUMINE® (a sedative and antispasmodic).

      • more

        UNI-PHARMA begins its journey shortly after the mid-20th century.
        It was founded in 1964 by the pioneering pharmacist and researcher Kleon Tsetis. His vision was to strengthen the presence of Greek companies in the pharmaceutical industry through the development, production, and distribution of innovative medicines. From its very first year, UNI-PHARMA stood out as it became the first company worldwide to introduce phenobarbital as an oral solution, LUMIDROPS®, as well as a combination of phenobarbital and homatropine, NOVALUMINE® (a sedative and antispasmodic).

      The dynamic start of UNI-PHARMA

      1977

      SALOSPIR® comes to Greece

      UNI-PHARMA brings SALOSPIR, the first acetylsalicylic acid product launched in Europe in the form of enteric-coated tablets, in 80 – 1,000® mg doses.

      • more

        UNI-PHARMA brings SALOSPIR, the first acetylsalicylic acid product launched in Europe in the form of enteric-coated tablets, in 80 – 1,000® mg doses.

      SALOSPIR® comes to Greece

      1990

      T4® brings expertise in thyroid gland diseases’ treatment

      T4®, a product for the treatment of thyroid gland diseases, is a specialized product available in 13 different strengths in individualized dosage regimens.

      • more

        T4®, a product for the treatment of thyroid gland diseases, is a specialized product available in 13 different strengths in individualized dosage regimens.

      T4® brings expertise in thyroid gland diseases’ treatment

      1992

      APOTEL® changed the way paracetamol is administered

      APOTEL®, introduced to the market in 1992, was the world’s first injectable formulation of paracetamol, based on a method of paracetamol solubilization, developed by UNI-PHARMA.

      • more

        APOTEL®, introduced to the market in 1992, was the world’s first injectable formulation of paracetamol, based on a method of paracetamol solubilization, developed by UNI-PHARMA.

      APOTEL® changed the way paracetamol is administered

      1998

      UNI-PHARMA acquires the European Patent

      In 1998 UNI-PHARMA obtained the European Patent for injectable paracetamol solutions and paracetamol in combination with other active substances.

      • more

        In 1998 UNI-PHARMA obtained the European Patent for injectable paracetamol solutions and paracetamol in combination with other active substances.

      UNI-PHARMA acquires the European Patent

      2005

      European Patent for Miniflam

      Miniflam, a non-steroidal anti-inflammatory drug in the form of a diclofenac gel suitable for topical administration, is granted a European patent in 2005.

      • more

        Miniflam, a non-steroidal anti-inflammatory drug in the form of a diclofenac gel suitable for topical administration, is granted a European patent in 2005.

      European Patent for Miniflam

      2009

      European Patent for Apotel Max

      The stable aqueous paracetamol solution of, Apotel Max, suitable for injectable administration, is granted a European patent.

      • more

        The stable aqueous paracetamol solution of, Apotel Max, suitable for injectable administration, is granted a European patent.

      European Patent for Apotel Max

      2012

      The construction of the bioclimatic, state of the art factory of UNI-PHARMA begins

      During the biggest economic recession that Greece has experienced post-war, the company’s management, headed by Mrs. Ioulia and Mrs. Eirini Tseti, begins the ambitious plan for the creation of its new bioclimatic plant in Kato Kifissia.

      • more

        During the biggest economic recession that Greece has experienced post-war, the company’s management, headed by Mrs. Ioulia and Mrs. Eirini Tseti, begins the ambitious plan for the creation of its new bioclimatic plant in Kato Kifissia.

      The construction of the bioclimatic, state of the art factory of UNI-PHARMA begins

      2014

      European Patent for Uniburn

      Uniburn, formulated with a combination of sucralfate, hyaluronic acid, and natural moisturizing agents such as natural yogurt, suitable for topical administration, is granted a European patent.

      • more

        Uniburn, formulated with a combination of sucralfate, hyaluronic acid, and natural moisturizing agents such as natural yogurt, suitable for topical administration, is granted a European patent.

      European Patent for Uniburn

      2015

      The vision of UNI-PHARMA 2 takes shape…

      The necessary validation works are completed, so as to put basic production lines into operation. The new facilities are a model of bioclimatic implementation, designed to taking full advantage of the climatic conditions for their operation while reducing any energy-consuming process, in full harmony with the natural environment.

      • more

        The necessary validation works are completed, so as to put basic production lines into operation. The new facilities are a model of bioclimatic implementation, designed to taking full advantage of the climatic conditions for their operation while reducing any energy-consuming process, in full harmony with the natural environment.

      The vision of UNI-PHARMA 2 takes shape...

      2016

      UNI-PHARMA becomes a proud member of the UN Global Compact

      In 2016, UNI-PHARMA joined the UN Global Compact, the United Nations’ global initiative, actively supporting its 10 principles across four thematic areas: human rights, labor standards, environment, and anti-corruption. Notably, UNI-PHARMA is internationally recognized as an official supplier to the United Nations, UNICEF, and the World Health Organization (WHO).

      • more

        In 2016, UNI-PHARMA joined the UN Global Compact, the United Nations’ global initiative, actively supporting its 10 principles across four thematic areas: human rights, labor standards, environment, and anti-corruption. Notably, UNI-PHARMA is internationally recognized as an official supplier to the United Nations, UNICEF, and the World Health Organization (WHO).

      UNI-PHARMA becomes a proud member of the UN Global Compact

      2018

      The challenge of SEV (Hellenic Federation of Enterprises)

      The election of the CEO of OFET (Tseti Group of Pharmaceutical Companies), Mrs. Ioulia Tseti to the General Council of the Hellenic Federation of Enterprises is expected to unfold in accordance with her firm belief that we can and must keep the bright minds in our country – after the bleeding of the brain drain and with a view to building a new Greece with strong characteristics of growth and extroversion, based on healthy businesses!

      • more

        The election of the CEO of OFET (Tseti Group of Pharmaceutical Companies), Mrs. Ioulia Tseti to the General Council of the Hellenic Federation of Enterprises is expected to unfold in accordance with her firm belief that we can and must keep the bright minds in our country – after the bleeding of the brain drain and with a view to building a new Greece with strong characteristics of growth and extroversion, based on healthy businesses!

      The challenge of SEV (Hellenic Federation of Enterprises)

      2019

      March – Most Powerful Women

      In March 2019, Mrs. Ioulia Tseti was included in the list of the 30 Most Powerful Women in Greece 2019 of Fortune Hellas magazine.

      • more

        In March 2019, Mrs. Ioulia Tseti was included in the list of the 30 Most Powerful Women in Greece 2019 of Fortune Hellas magazine.

      March – Most Powerful Women

      2019

      April – OFET’s Distinction at Creative Greece

      The Tseti Pharmaceutical Group (OFET) was distinguished at the annual Creative Greece 2019 awards. During the award ceremony, the Group’s President and CEO, Ioulia Tseti, announced the establishment of a new medicinal plant extracts unit, Uniherbo, which will also serve as a Research Institute for students.

      • more

        The Tseti Pharmaceutical Group (OFET) was distinguished at the annual Creative Greece 2019 awards. During the award ceremony, the Group’s President and CEO, Ioulia Tseti, announced the establishment of a new medicinal plant extracts unit, Uniherbo, which will also serve as a Research Institute for students.

      April - OFET's Distinction at Creative Greece

      2019

      July – Honorary Award

      Honorary Award to Mrs. Ioulia and Mrs. Eirini Tseti for their overall contribution to the pharmaceutical industry, health and business from BEST IN PHARMACY 2019.

      • more

        Honorary Award to Mrs. Ioulia and Mrs. Eirini Tseti for their overall contribution to the pharmaceutical industry, health and business from BEST IN PHARMACY 2019.

      July – Honorary Award

      2019

      December – Renovation of the historic UNI-PHARMA factory

      The renovation – maintenance of the first historic UNI-PHARMA factory in Kifissia is completed.

      • more

        The renovation – maintenance of the first historic UNI-PHARMA factory in Kifissia is completed.

      December - Renovation of the historic UNI-PHARMA factory

      2019

      UNI-PHARMA Adopts and Implements ESG Criteria

      In 2019, UNI-PHARMA embraced the Sustainable Development Goals (SDGs) and integrated sustainability standards into its daily operations. The company’s leadership aims to further enhance its social impact, while simultaneously reducing its environmental and energy footprint, remaining committed to effective corporate governance and ethical business practices.

      • more

        In 2019, UNI-PHARMA embraced the Sustainable Development Goals (SDGs) and integrated sustainability standards into its daily operations. The company’s leadership aims to further enhance its social impact, while simultaneously reducing its environmental and energy footprint, remaining committed to effective corporate governance and ethical business practices.

      UNI-PHARMA Adopts and Implements ESG Criteria

      2020

      January – ACCI Award

      Environment and Green Development Award of the Athens Chamber of Commerce and Industry to UNI-PHARMA.

      • more

        Environment and Green Development Award of the Athens Chamber of Commerce and Industry to UNI-PHARMA.

      January – ACCI Award

      2020

      January – February – Ioulia Tseti, at the helm of UN Global Compact Network Hellas

      Tseti Group of Pharmaceutical Companies CEO, Mrs. Ioulia Tseti, achieved an important distinction – overall for our country and the field of sustainable development –, as she was elected President of the first Board of Directors of Global Compact Hellas, which is the Local Network of the UN Global Compact.

      • more

        Tseti Group of Pharmaceutical Companies CEO, Mrs. Ioulia Tseti, achieved an important distinction – overall for our country and the field of sustainable development –, as she was elected President of the first Board of Directors of Global Compact Hellas, which is the Local Network of the UN Global Compact.

      January – February – Ioulia Tseti, at the helm of UN Global Compact Network Hellas

      2020

      February – Growth Award: UNI-PHARMA among the 18 best companies in Greece

      UNI-PHARMA was among the 18 best companies in the country out of a total of 8,000 at the Growth Awards competition, which took place on the evening of Monday, February 17, 2020 at the Athens Concert Hall (Megaron). The Awards, which best highlight healthy entrepreneurship, innovation and excellence in a challenging environment are organized by Grant Thornton and Eurobank.

      • more

        UNI-PHARMA was among the 18 best companies in the country out of a total of 8,000 at the Growth Awards competition, which took place on the evening of Monday, February 17, 2020 at the Athens Concert Hall (Megaron). The Awards, which best highlight healthy entrepreneurship, innovation and excellence in a challenging environment are organized by Grant Thornton and Eurobank.

      February – Growth Award: UNI-PHARMA among the 18 best companies in Greece

      2020

      February – Gold Award

      To UNI-PHARMA’s Repel products, following a vote by iatronet, at the 11th Health Expo Athens.

      • more

        To UNI-PHARMA’s Repel products, following a vote by iatronet, at the 11th Health Expo Athens.

      February - Gold Award

      2020

      March – April: The big donations due to the pandemic – COVID-19

      In the most serious public health crisis the planet has known, Mrs. Ioulia Tseti donates to the Greek and Cypriot health system Unikinon – with chloroquine as an active ingredient, to help patients hospitalized with SARS CoV-2. The production of the drug began almost immediately at the UNI-PHARMA facilities in Kato Kifissia. In the first pandemic wave, chloroquine was cited as a possible successful treatment to tackle the pandemic. Donations amounted to EUR 24 million free Unikinon doses for the (Hellenic) National Health System and 60,000 doses for the Cypriot health system.

      • more

        In the most serious public health crisis the planet has known, Mrs. Ioulia Tseti donates to the Greek and Cypriot health system Unikinon – with chloroquine as an active ingredient, to help patients hospitalized with SARS CoV-2. The production of the drug began almost immediately at the UNI-PHARMA facilities in Kato Kifissia. In the first pandemic wave, chloroquine was cited as a possible successful treatment to tackle the pandemic. Donations amounted to EUR 24 million free Unikinon doses for the (Hellenic) National Health System and 60,000 doses for the Cypriot health system.

      March – April: The big donations due to the pandemic – COVID-19

      2020

      September – UNI-PHARMA Pharmacy Company of the Year

      The Tseti Pharmaceutical Group (OFET) won a total of seven distinctions (Gold, Silver, and Platinum) at the Best in Pharmacy Awards 2020, including the highest honor, “Pharmacy Company of the Year,” awarded to UNI-PHARMA. UNI-PHARMA also received two Gold Awards for being a leading socially responsible company, recognized for its large donations of Unikinon (chloroquine) and antiseptics during the SARS COVID-19 pandemic. Additionally, UNI-PHARMA received two Silver Awards, one for being a top Green company and another for the launch of the TONOSAN dietary supplement line.

      • more

        The Tseti Pharmaceutical Group (OFET) won a total of seven distinctions (Gold, Silver, and Platinum) at the Best in Pharmacy Awards 2020, including the highest honor, “Pharmacy Company of the Year,” awarded to UNI-PHARMA. UNI-PHARMA also received two Gold Awards for being a leading socially responsible company, recognized for its large donations of Unikinon (chloroquine) and antiseptics during the SARS COVID-19 pandemic. Additionally, UNI-PHARMA received two Silver Awards, one for being a top Green company and another for the launch of the TONOSAN dietary supplement line.

      September - UNI-PHARMA Pharmacy Company of the Year

      2020

      December – UNI-PHARMA among the 25 Most Sustainable Companies in Greece

      Since December 7, 2020, Tsetis Group of Pharmaceutical Companies has been in the leading group of The Most Sustainable Companies in Greece 2020, the 25 companies with the greatest sustainable growth. This is a technical evaluation, carried out by the executives of the Quality Net Foundation Network that makes the Most Sustainable Companies title for the OFET industries, UNI-PHARMA and InterMed, particularly important.

      • more

        Since December 7, 2020, Tsetis Group of Pharmaceutical Companies has been in the leading group of The Most Sustainable Companies in Greece 2020, the 25 companies with the greatest sustainable growth. This is a technical evaluation, carried out by the executives of the Quality Net Foundation Network that makes the Most Sustainable Companies title for the OFET industries, UNI-PHARMA and InterMed, particularly important.

      December – UNI-PHARMA among the 25 Most Sustainable Companies in Greece

      2021

      July – Diamonds of Greek Economy Award for OFET

      The Tsetis Group of Pharmaceutical Companies (OFET) was once again honored with the Diamonds of the Greek Economy Award, organized by New Times Publishing Group. OFET was recognized for its ongoing investments in a challenging and demanding environment, its significant financial growth, and its targeted corporate responsibility strategy. This strategy encompasses initiatives for society, the environment, science, research, and supporting the next generation.

      • more

        The Tsetis Group of Pharmaceutical Companies (OFET) was once again honored with the Diamonds of the Greek Economy Award, organized by New Times Publishing Group. OFET was recognized for its ongoing investments in a challenging and demanding environment, its significant financial growth, and its targeted corporate responsibility strategy. This strategy encompasses initiatives for society, the environment, science, research, and supporting the next generation.

      July - Diamonds of Greek Economy Award for OFET

      2021

      September – Ioulia Tseti awarded World Woman Leader of Pharmaceutical Industry & Social Contribution

      Ioulia Tseti, President of UNI-PHARMA, was honored as World Woman Leader of Pharmaceutical Industry & Social Contribution at the Who is Who International Awards 2021.

      • more

        Ioulia Tseti, President of UNI-PHARMA, was honored as World Woman Leader of Pharmaceutical Industry & Social Contribution at the Who is Who International Awards 2021.

      September – Ioulia Tseti awarded World Woman Leader of Pharmaceutical Industry & Social Contribution

      2021

      September – Large donation of the “KLEON TSETIS” Foundation of an amphitheater at the NKUA School of Pharmacy

      On September 27, 2021, Julia Tseti, via the Kleon Tsetis NPO Foundation, made a large donation of an interactive, 100 seats amphitheater to the School of Pharmacy of the National and Kapodistrian University of Athens, amounting to 120,000 euros. The donation symbolically coincides with the celebration of the 200th anniversary of the Greek Revolution.

      • more

        On September 27, 2021, Julia Tseti, via the Kleon Tsetis NPO Foundation, made a large donation of an interactive, 100 seats amphitheater to the School of Pharmacy of the National and Kapodistrian University of Athens, amounting to 120,000 euros. The donation symbolically coincides with the celebration of the 200th anniversary of the Greek Revolution.

      September – Large donation of the

      2022

      February – Cooperation with UNHCR

      Working with UNHCR and UNHCR Representative in Greece, Ms. Maria Clara Martin, to activate targeted actions for refugees. The aim is for these vulnerable groups to be able to integrate into both society and the labor market.

      • more

        Working with UNHCR and UNHCR Representative in Greece, Ms. Maria Clara Martin, to activate targeted actions for refugees. The aim is for these vulnerable groups to be able to integrate into both society and the labor market.

      February – Cooperation with UNHCR

      2022

      June – Cutting-edge collaborations with FORTH

      The Tsetis Group of Pharmaceutical Companies announced groundbreaking collaborations in the field of biotechnology with two of Greece’s leading institutes: the Institute of Molecular Biology and Biotechnology in Crete and the Institute of Biomedical Research in Ioannina. Both institutes operate under the umbrella of the Foundation for Research and Technology-Hellas (FORTH).

      • more

        The Tsetis Group of Pharmaceutical Companies announced groundbreaking collaborations in the field of biotechnology with two of Greece’s leading institutes: the Institute of Molecular Biology and Biotechnology in Crete and the Institute of Biomedical Research in Ioannina. Both institutes operate under the umbrella of the Foundation for Research and Technology-Hellas (FORTH).

      June - Cutting-edge collaborations with FORTH

      2022

      June – Ioulia Tseti honored as an Honorary Doctor of the Department of Pharmacy at NKUA

      This is the highest acclaim of the academic community towards Mrs. Ioulia Tseti, honoring her multiannual research work, but also her ceaseless and tireless actions in aid of the society, the younger generation, and the environment. The investiture ceremony took place in the presence of the Rector’s Authorities, His Eminence the Metropolitan of Arta, professors and students, executives of the Tsetis Group, representatives of the business world and the press.

      • more

        This is the highest acclaim of the academic community towards Mrs. Ioulia Tseti, honoring her multiannual research work, but also her ceaseless and tireless actions in aid of the society, the younger generation, and the environment. The investiture ceremony took place in the presence of the Rector’s Authorities, His Eminence the Metropolitan of Arta, professors and students, executives of the Tsetis Group, representatives of the business world and the press.

      June – Ioulia Tseti honored as an Honorary Doctor of the Department of Pharmacy at NKUA

      2022

      June – UNI-PHARMA receives the ACCI award for Corporate Social Responsibility

      UNI-PHARMA was distinguished with the ACCI Business Award for Corporate Social Responsibility on Thursday June 22. The President and CEO of the Tsetis Pharmaceutical Companies Ioulia Tseti as well as the CFO Eirini Tseti received the award by the Prime Minister, Kyriakos Mitsotakis, in the presence of the President of The ACCI, Yiannis Bratakos.

      • more

        UNI-PHARMA was distinguished with the ACCI Business Award for Corporate Social Responsibility on Thursday June 22. The President and CEO of the Tsetis Pharmaceutical Companies Ioulia Tseti as well as the CFO Eirini Tseti received the award by the Prime Minister, Kyriakos Mitsotakis, in the presence of the President of The ACCI, Yiannis Bratakos.

      June - UNI-PHARMA receives the ACCI award for Corporate Social Responsibility

      2022

      July – Honorary Distinction from the University of Ioannina

      Ioulia Tseti received a distinction for her continuous and targeted efforts towards society, research, the younger generation, and the environment. The award was granted by the Scientific and Organizing Committee of the 8th International Summer University in Kastelorizo.

      • more

        Ioulia Tseti received a distinction for her continuous and targeted efforts towards society, research, the younger generation, and the environment. The award was granted by the Scientific and Organizing Committee of the 8th International Summer University in Kastelorizo.

      July - Honorary Distinction from the University of Ioannina

      2023

      January – UNI-PHARMA Top Employer 2023 in Greece

      UNI-PHARMA has been certified as a Top Employer 2023 in Greece by the Top Employers Institute, the leading global authority on recognizing and promoting excellence in human resources strategies. UNI-PHARMA and InterMed become the first Greek pharmaceutical companies to achieve this prestigious certification.

      • more

        UNI-PHARMA has been certified as a Top Employer 2023 in Greece by the Top Employers Institute, the leading global authority on recognizing and promoting excellence in human resources strategies. UNI-PHARMA and InterMed become the first Greek pharmaceutical companies to achieve this prestigious certification.

      January - UNI-PHARMA Top Employer 2023 in Greece

      2023

      February – UNI-PHARMA President Ioulia Tseti named an Inspirational Mentor

      UNI-PHARMA President and CEO Ioulia Tseti has been named one of the Inspirational Mentors, a prestigious initiative established by the non-profit educational organization Junior Achievement Greece. This program highlights 70 influential figures from Greece who inspire and empower the next generation. As part of her mentorship, the CEO of OFET collaborated with high school students from the 2nd Vocational High School (EPAL) in Kozani. Together, they worked on creating their own virtual business startup as part of the “Virtual Enterprise – Company Program” competition.

      • more

        UNI-PHARMA President and CEO Ioulia Tseti has been named one of the Inspirational Mentors, a prestigious initiative established by the non-profit educational organization Junior Achievement Greece. This program highlights 70 influential figures from Greece who inspire and empower the next generation. As part of her mentorship, the CEO of OFET collaborated with high school students from the 2nd Vocational High School (EPAL) in Kozani. Together, they worked on creating their own virtual business startup as part of the “Virtual Enterprise – Company Program” competition.

      February - UNI-PHARMA President Ioulia Tseti named an Inspirational Mentor

      2023

      March – Recognition in “The Most Sustainable Companies” initiative

      UNI-PHARMA participated in the Sustainability Performance Directory 2023, an initiative by the Quality Net Foundation, and following a thorough evaluation, was ranked among the 35 leading companies shaping the business map of sustainable development in Greece. This recognition was based on the company’s performance in three key criteria: Environment – Society – Corporate Governance (ESG).

      • more

        UNI-PHARMA participated in the Sustainability Performance Directory 2023, an initiative by the Quality Net Foundation, and following a thorough evaluation, was ranked among the 35 leading companies shaping the business map of sustainable development in Greece. This recognition was based on the company’s performance in three key criteria: Environment – Society – Corporate Governance (ESG).

      March - Recognition in

      2023

      March – Award to Ioulia Tseti for contributions to women’s entrepreneurship

      UNI-PHARMA President and CEO Ioulia Tseti was honored for her significant contributions to modern women’s entrepreneurship at the 2nd Women’s Conference titled “Modern Women / Successful Managers”, organized by Business Review Magazine. The conference was held under the auspices of the Athens Chamber of Commerce and Industry (ACCI), the General Secretariat for Demographic and Family Policy and Gender Equality, the Greek Association of Women Entrepreneurs (EGE), and the initiative Ella-dika Mas.

      • more

        UNI-PHARMA President and CEO Ioulia Tseti was honored for her significant contributions to modern women’s entrepreneurship at the 2nd Women’s Conference titled “Modern Women / Successful Managers”, organized by Business Review Magazine. The conference was held under the auspices of the Athens Chamber of Commerce and Industry (ACCI), the General Secretariat for Demographic and Family Policy and Gender Equality, the Greek Association of Women Entrepreneurs (EGE), and the initiative Ella-dika Mas.

      March - Award to Ioulia Tseti for contributions to women’s entrepreneurship

      2023

      April – Prix Galien 2023 honorary award for UNI-PHARMA

      The Tsetis Group of Pharmaceutical Companies received the honorary distinction of “Honored Pharmaceutical Innovation Company” at the Prix Galien 2023 awards. This recognition celebrates the company’s advancements in pharmaceutical innovation and its significant contribution to the Greek economy.

      • more

        The Tsetis Group of Pharmaceutical Companies received the honorary distinction of “Honored Pharmaceutical Innovation Company” at the Prix Galien 2023 awards. This recognition celebrates the company’s advancements in pharmaceutical innovation and its significant contribution to the Greek economy.

      April - Prix Galien 2023 honorary award for UNI-PHARMA

      2023

      May – UNI-PHARMA supports the “Exelixi Zois” organization

      UNI-PHARMA proudly supports the mission of the “Exelixi Zois” (Evolution Of Life) organization, which focuses on the care and holistic support of adolescents, young adults, and individuals up to 25 years old transitioning from institutional care environments. The organization’s support is provided through a combination of programs, including educational initiatives, psychosocial empowerment, career guidance, access to culture and sports, and semi-autonomy and autonomy training. These efforts aim to foster their creative integration into society, helping them leave behind the challenges of institutional care and build a brighter future.

      • more

        UNI-PHARMA proudly supports the mission of the “Exelixi Zois” (Evolution Of Life) organization, which focuses on the care and holistic support of adolescents, young adults, and individuals up to 25 years old transitioning from institutional care environments. The organization’s support is provided through a combination of programs, including educational initiatives, psychosocial empowerment, career guidance, access to culture and sports, and semi-autonomy and autonomy training. These efforts aim to foster their creative integration into society, helping them leave behind the challenges of institutional care and build a brighter future.

      May - UNI-PHARMA supports the

      2023

      November – UNI-PHARMA named Growth Winner at the Growth Awards 2023

      Following a comprehensive evaluation across various key business and financial indicators, UNI-PHARMA was honored as a Growth Winner at the Growth Awards 2023, an event organized by Grant Thornton and Eurobank to recognize excellence in growth and competitiveness. The pharmaceutical company stood out among 8,000 businesses nationwide, being one of the six companies with the most significant impact in terms of growth and international outreach.

      • more

        Following a comprehensive evaluation across various key business and financial indicators, UNI-PHARMA was honored as a Growth Winner at the Growth Awards 2023, an event organized by Grant Thornton and Eurobank to recognize excellence in growth and competitiveness. The pharmaceutical company stood out among 8,000 businesses nationwide, being one of the six companies with the most significant impact in terms of growth and international outreach.

      November - UNI-PHARMA named Growth Winner at the Growth Awards 2023

      2024

      January – UNI-PHARMA Top Employer in Greece for the second consecutive year

      The pharmaceutical companies UNI-PHARMA and InterMed have been recognized as Top Employers in Greece for the second consecutive year by the Top Employers Institute. This prestigious distinction highlights their unwavering commitment to building a better workplace by prioritizing employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected organizational culture.

      • more

        The pharmaceutical companies UNI-PHARMA and InterMed have been recognized as Top Employers in Greece for the second consecutive year by the Top Employers Institute. This prestigious distinction highlights their unwavering commitment to building a better workplace by prioritizing employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected organizational culture.

      January - UNI-PHARMA Top Employer in Greece for the second consecutive year

      2024

      February – Ioulia Tseti as an Inspirational Mentor for EPAL Mykonos students

      UNI-PHARMA President and CEO Ioulia Tseti collaborated with the students of the Vocational High School (EPAL) in Mykonos, guiding them in the creation of a virtual business. This initiative reflects her dedication to inspiring and empowering young minds to develop entrepreneurial skills and creative thinking.

      • more

        UNI-PHARMA President and CEO Ioulia Tseti collaborated with the students of the Vocational High School (EPAL) in Mykonos, guiding them in the creation of a virtual business. This initiative reflects her dedication to inspiring and empowering young minds to develop entrepreneurial skills and creative thinking.

      February - Ioulia Tseti as an Inspirational Mentor for EPAL Mykonos students

      2024

      May – “Kotinos Olympic Wreath” responsibility distinction for OFET

      The Tsetis Group of Pharmaceutical Companies (OFET) was honored with the “Kotinos Olympic Wreath” Responsibility Distinction by EBEN.GR – European Business Ethics Network. The award was given during the Responsible Management Excellence Awards 2024, held on May 29. OFET stood out among companies operating in Greece, both in the private and public sectors, that were evaluated, scored, and certified based on EBEN’s Responsible Management Excellence model.

      • more

        The Tsetis Group of Pharmaceutical Companies (OFET) was honored with the “Kotinos Olympic Wreath” Responsibility Distinction by EBEN.GR – European Business Ethics Network. The award was given during the Responsible Management Excellence Awards 2024, held on May 29. OFET stood out among companies operating in Greece, both in the private and public sectors, that were evaluated, scored, and certified based on EBEN’s Responsible Management Excellence model.

      May -

      2024

      June – Ioulia Tseti honored as Doctor of Pharmacy by the University of Patras

      On Thursday, June 13, 2024, Ioulia Tseti, President of UNI-PHARMA, was awarded the title of Honorary Doctor of Pharmacy by the University of Patras. This prestigious recognition highlights her significant contributions to the field of pharmacy and her enduring impact on the pharmaceutical industry.

      • more

        On Thursday, June 13, 2024, Ioulia Tseti, President of UNI-PHARMA, was awarded the title of Honorary Doctor of Pharmacy by the University of Patras. This prestigious recognition highlights her significant contributions to the field of pharmacy and her enduring impact on the pharmaceutical industry.

      June - Ioulia Tseti honored as Doctor of Pharmacy by the University of Patras

      2024

      September – Honorary distinction for UNI-PHARMA by the Aristotle University of Thessaloniki

      UNI-PHARMA received an honorary distinction from the Aristotle University of Thessaloniki (AUTh) in recognition of its contributions to funding research and innovation at the university. This accolade underscores UNI-PHARMA’s commitment to supporting academic excellence and advancing scientific progress.

      • more

        UNI-PHARMA received an honorary distinction from the Aristotle University of Thessaloniki (AUTh) in recognition of its contributions to funding research and innovation at the university. This accolade underscores UNI-PHARMA’s commitment to supporting academic excellence and advancing scientific progress.

      September - Honorary distinction for UNI-PHARMA by the Aristotle University of Thessaloniki

      2024

      October – Ioulia Tseti named Woman of the Year 2024 at CPHI in Milan

      On October 8, 2024, Ioulia Tseti, President of UNI-PHARMA, was honored as Woman of the Year 2024 during the CPHI 2024 exhibition in Milan. CPHI, a cornerstone event for the global pharmaceutical industry for over 35 years, brings together health sector leaders from around the world. Ioulia Tseti received the award in recognition of her dedication to innovation, sustainable development, and social responsibility. She was celebrated as a “true visionary and pioneer in the field, leaving a significant mark on the global pharmaceutical industry.”.

      • more

        On October 8, 2024, Ioulia Tseti, President of UNI-PHARMA, was honored as Woman of the Year 2024 during the CPHI 2024 exhibition in Milan. CPHI, a cornerstone event for the global pharmaceutical industry for over 35 years, brings together health sector leaders from around the world. Ioulia Tseti received the award in recognition of her dedication to innovation, sustainable development, and social responsibility. She was celebrated as a “true visionary and pioneer in the field, leaving a significant mark on the global pharmaceutical industry.”.

      October - Ioulia Tseti named Woman of the Year 2024 at CPHI in Milan

      2024

      December – UNI-PHARMA recognized as a True Leader by ICAP

      UNI-PHARMA has been honored as a True Leader of the Greek economy, a distinction awarded by ICAP CRIF. This recognition is the result of an in-depth analysis conducted by ICAP experts, which evaluated the financial performance and EBITDA data of the 500 most profitable companies in Greece for 2023. UNI-PHARMA was distinguished for its performance and strategic growth among the 200 corporate groups in Greece with the highest EBITDA profits.

      • more

        UNI-PHARMA has been honored as a True Leader of the Greek economy, a distinction awarded by ICAP CRIF. This recognition is the result of an in-depth analysis conducted by ICAP experts, which evaluated the financial performance and EBITDA data of the 500 most profitable companies in Greece for 2023. UNI-PHARMA was distinguished for its performance and strategic growth among the 200 corporate groups in Greece with the highest EBITDA profits.

      December - UNI-PHARMA recognized as a True Leader by ICAP

      2025

      January – UNI-PHARMA certified as a Top Employer for the third consecutive year

      For the third consecutive year, UNI-PHARMA and InterMed have been certified as Top Employers in Greece by the Top Employers Institute, the leading global organization dedicated to recognizing and promoting excellence in human resources strategies. This distinction highlights their unwavering commitment to creating a better workplace, with a strong focus on employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected work culture.

      • more

        For the third consecutive year, UNI-PHARMA and InterMed have been certified as Top Employers in Greece by the Top Employers Institute, the leading global organization dedicated to recognizing and promoting excellence in human resources strategies. This distinction highlights their unwavering commitment to creating a better workplace, with a strong focus on employee development, holistic well-being, and fostering a sustainable, inclusive, and globally connected work culture.

      January - UNI-PHARMA certified as a Top Employer for the third consecutive year

      2025

      March – Triple Gold Distinction at the Green Brand Awards 2025

      UNI-PHARMA was honored with Gold Awards in three categories:

      Green Building – for UNI-PHARMA’s bioclimatic, state-of-the-art manufacturing facility, the largest investment in the Greek pharmaceutical industry, which began and was completed during the period of economic crisis.

      Green Corporate Training – for the company’s educational initiatives in the field of sustainability, integrating green practices and environmental awareness into its corporate culture.

      Low Energy Equipment – for its systematic investment in low energy consumption equipment, contributing to the reduction of its environmental footprint.

      • more

        UNI-PHARMA was honored with Gold Awards in three categories:

        Green Building – for UNI-PHARMA’s bioclimatic, state-of-the-art manufacturing facility, the largest investment in the Greek pharmaceutical industry, which began and was completed during the period of economic crisis.

        Green Corporate Training – for the company’s educational initiatives in the field of sustainability, integrating green practices and environmental awareness into its corporate culture.

        Low Energy Equipment – for its systematic investment in low energy consumption equipment, contributing to the reduction of its environmental footprint.

      March - Triple Gold Distinction at the Green Brand Awards 2025

      2025

      April – Julia Tsetis honored at Cardio Athena 2025

      Within the framework of the 21st Congress of Cardiovascular Medicine, Cardio Athena 2025, the President of the Congress, Konstantinos Tsioufis, presented an award to the President and CEO of the Tsetis Pharmaceutical Group, Julia Tsetis, for her invaluable contribution to the Greek pharmaceutical industry and to the promotion of cardiovascular health among Greek patients.

      • more

        Within the framework of the 21st Congress of Cardiovascular Medicine, Cardio Athena 2025, the President of the Congress, Konstantinos Tsioufis, presented an award to the President and CEO of the Tsetis Pharmaceutical Group, Julia Tsetis, for her invaluable contribution to the Greek pharmaceutical industry and to the promotion of cardiovascular health among Greek patients.

      April - Julia Tsetis honored at Cardio Athena 2025

      2025

      April – LactoLevure® named Best Nutraceutical at the Prix Galien Awards 2025

      LactoLevure®, a research and development product of UNI-PHARMA, received the Prix Galien Award in the Nutraceuticals category, during the award ceremony held on April 24.

      LactoLevure® is a breakthrough formulation that not only protects and restores the intestinal microbiota, but also sets itself apart from other probiotics on the market by innovating in two key areas:

      It is the first probiotic blend launched in Greece, with strains that have been scientifically proven to support not only prevention but also the treatment of medical conditions, such as the eradication of Helicobacter pylori and the management of Irritable Bowel Syndrome (IBS).

      It is the only probiotic in Greece included in official scientific guidelines, both national and international, for the management of specific medical conditions.

      • more

        LactoLevure®, a research and development product of UNI-PHARMA, received the Prix Galien Award in the Nutraceuticals category, during the award ceremony held on April 24.

        LactoLevure® is a breakthrough formulation that not only protects and restores the intestinal microbiota, but also sets itself apart from other probiotics on the market by innovating in two key areas:

        It is the first probiotic blend launched in Greece, with strains that have been scientifically proven to support not only prevention but also the treatment of medical conditions, such as the eradication of Helicobacter pylori and the management of Irritable Bowel Syndrome (IBS).

        It is the only probiotic in Greece included in official scientific guidelines, both national and international, for the management of specific medical conditions.

      April - LactoLevure® named Best Nutraceutical at the Prix Galien Awards 2025

      2025

      July – Double Honor at the Protagonists of the Greek Economy Awards 2025

      Julia Tsetis was honored with the Women’s Entrepreneurship Excellence Award for her meaningful contribution to the pharmaceutical, health, and business sectors on Monday, July 14, at the opening ceremony of the “Protagonists of the Greek Economy Awards 2025” organized by Direction Business Network.

      UNI-PHARMA received the award in the “Growth and Investments” category, in recognition of its steady development and dynamic investment initiatives.

      • more

        Julia Tsetis was honored with the Women’s Entrepreneurship Excellence Award for her meaningful contribution to the pharmaceutical, health, and business sectors on Monday, July 14, at the opening ceremony of the “Protagonists of the Greek Economy Awards 2025” organized by Direction Business Network.

        UNI-PHARMA received the award in the “Growth and Investments” category, in recognition of its steady development and dynamic investment initiatives.

      July - Double Honor at the Protagonists of the Greek Economy Awards 2025
      Facilities & Technology
      Εγκαταστάσεις & Τεχνολογία

      The current production facilities of UNI-PHARMA are part of the largest investment made in recent years in the pharmaceutical industry in Greece.

      New facilities, new Research, Development and Innovation capabilities

      The headquarters of UNI-PHARMA are in Kato Kifissia, in new facilities which operate in accordance with modern international standards, utilizing cutting-edge technologies that create the conditions for research, development and innovation.

      The current production facilities of UNI-PHARMA are part of the largest investment made in recent years in the pharmaceutical industry in Greece. They were completed in 2015, after an extension of the older ones and in full harmony with the environment. They are a model of bioclimatic implementation, since they take full advantage of the climatic conditions for their operation, while at the same time great effort is made to reduce any energy-consuming process.

      They are equipped with the latest technology, production, packaging and quality control systems, while all processes are monitored and controlled by new, innovative and modern electronic systems (BMS).

      Now the total area of our production plants reaches 14,000 m2, 12,400 m2 of which are production and packaging areas. The company’s final products are stored in a independent space of 11,000 m2, from which they are shipped to the markets.

      The production capacity of the new facilities amounts to 2 billion tablets and 50 million units of injectables per year. In specific, here are produced and packaged:

      Solids: various forms of tablets (plain, coated, controlled-release), capsules, granules in sachets as well as products requiring low humidity areas (effervescent tablets and granules, as well as soluble granules and powders in sachets and vials).

      Semi-solids: creams, ointments, gels, and suppositories.

      Liquids: oral solutions (syrups, elixirs and suspensions in vials, solutions in drops and in single-dose vials) and liquids for external use.

      Injectable: injectable products, either by sterile filtration or by terminal sterilization.

      Quality Assurance System

      The principle of UNI-PHARMA is that “one cannot ensure health without first ensuring the quality of (one’s) products”.

      Investing in Quality and Safety

      The principle of UNI-PHARMA is based on the philosophy, “one cannot ensure health if one does not first ensure the quality of products”. This is why high quality and safety of medicines is not just a priority. It is the responsibility of each member of the UNI-PHARMA team.

      This is the reason UNI-PHARMA invests dynamically in modern production units and advanced technologies, in proactive people with high qualifications and a sense of responsibility, in organizational systems that assure responsibility and participation, in partners and academic institutions that share the same values.

      More specifically, it follows the most efficient and effective quality control procedures. It fully complies with regulatory requirements and internationally recognized good practices, while all production stages are implemented according to a quality management system, certified by ISO9001:2008 and GMP, which provides, among others:
      • Standard and validated production processes.
      • Intensive quality controls at all stages of the production process.
      • Recording, analyzing and managing any complaints and deviations from the required quality standards.

      Quality assurance is a collective responsibility of all UNI-PHARMA workforce and is attained by the collective effort of employees from all departments, safeguarding the quality, safety and effectiveness of products. See the Quality Policy of UNI-PHARMA here.